NewAmsterdam Pharma Company NV
NAMSW10.410USD
0.000
시장 운영 시간 （ET）시세는 15분 지연됩니다
0.00시가총액
--P/E TTM
자세한 내용은 NewAmsterdam Pharma Company NV 회사
NewAmsterdam Pharma Company NV is a Netherlands based company. NewAmsterdam Pharma operates as a clinical-stage company and focuses on the research and development of transformative oral therapies for major cardiometabolic diseases. The Company is investigating obicetrapib, an oral, low-dose and once-daily, cholesteryl ester transfer protein (CETP) inhibitor, as the low-density lipoprotein cholesterol (LDL-C) lowering therapy to be used as an adjunct statin therapy for high-risk cardiovascular disease (CVD) patients. The Company is also testing obicetrapib as a fixed-dose combination therapy with ezetimibe in a secondary Phase 2 trial, ROSE2, for other diseases such as Alzheimer’s disease. The Company strives to offer its products around the world.
회사 정보
종목 코드 NAMSW
회사 이름NewAmsterdam Pharma Company NV
상장일Nov 23, 2022
CEODr. Michael Harvey Davidson, M.D.
직원 수- -
유형Company Warrant
회계 연도 종료- -
주소Gooimeer 2-35
도시NAARDEN
증권 거래소NASDAQ Global Market Consolidated
국가Netherlands
우편 번호1411 DC
전화31352062971
웹사이트https://ir.newamsterdampharma.com/
종목 코드 NAMSW
상장일Nov 23, 2022
CEODr. Michael Harvey Davidson, M.D.
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. William H. (Will) Lewis, J.D.
Mr. William H. (Will) Lewis, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Mark C. Mckenna
Mr. Mark C. Mckenna
Independent Director
Independent Director
--
--
Mr. Wouter Joustra
Mr. Wouter Joustra
Independent Director
Independent Director
--
--
Ms. Adele M. Gulfo
Ms. Adele M. Gulfo
Independent Director
Independent Director
--
--
Dr. Louis Lange, M.D., Ph.D.
Dr. Louis Lange, M.D., Ph.D.
Independent Director
Independent Director
--
--
Ms. Janneke Van Der Kamp
Ms. Janneke Van Der Kamp
Temporary Non-Executive Director
Temporary Non-Executive Director
--
--
Dr. James N. Topper, M.D., Ph.D.
Dr. James N. Topper, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Nicholas Downing, M.D.
Dr. Nicholas Downing, M.D.
Director
Director
--
--
Ms. Louise Kooij
Ms. Louise Kooij
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Dr. Michael Harvey Davidson, M.D.
Dr. Michael Harvey Davidson, M.D.
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. William H. (Will) Lewis, J.D.
Mr. William H. (Will) Lewis, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Mark C. Mckenna
Mr. Mark C. Mckenna
Independent Director
Independent Director
--
--
Mr. Wouter Joustra
Mr. Wouter Joustra
Independent Director
Independent Director
--
--
Ms. Adele M. Gulfo
Ms. Adele M. Gulfo
Independent Director
Independent Director
--
--
Dr. Louis Lange, M.D., Ph.D.
Dr. Louis Lange, M.D., Ph.D.
Independent Director
Independent Director
--
--
Ms. Janneke Van Der Kamp
Ms. Janneke Van Der Kamp
Temporary Non-Executive Director
Temporary Non-Executive Director
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Sat, Jul 5
마지막 업데이트: Sat, Jul 5
주주
주주 유형
주주
주주
비율
Other
100.00%
주주
주주
비율
Other
100.00%
주주 유형
주주
비율
Other
100.00%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
26
1.31M
0.00%
-654.24K
2025Q1
28
1.31M
0.00%
-682.10K
2024Q4
31
1.32M
0.00%
-986.85K
2024Q3
38
1.33M
0.00%
-1.41M
2024Q2
50
1.30M
0.00%
-1.97M
2024Q1
49
1.44M
0.00%
-1.61M
2023Q4
46
1.64M
0.00%
-1.32M
2023Q3
45
1.61M
0.00%
-1.70M
2023Q2
45
1.95M
0.00%
-1.68M
2023Q1
44
2.30M
0.00%
-1.32M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Frazier Life Sciences Management, L.P.
500.33K
0%
--
--
Mar 31, 2025
RA Capital Management, LP
333.33K
0%
--
--
Mar 31, 2025
Affinity Asset Advisors LLC
241.96K
0%
+4.02K
+1.69%
Mar 31, 2025
Bain Capital Life Sciences Investors, LLC
100.00K
0%
--
--
Mar 31, 2025
Deerfield Management Company, L.P.
92.79K
0%
--
--
Mar 31, 2025
Laurion Capital Management LP
16.67K
0%
--
--
Mar 31, 2025
HRT Financial LP
--
0%
-13.65K
-100.00%
Mar 31, 2025
Wolverine Asset Management, LLC
8.88K
0%
-3.81K
-30.01%
Mar 31, 2025
Vestcor Inc
9.63K
0%
--
--
Mar 31, 2025
UBS Financial Services, Inc.
2.38K
0%
-100.00
-4.03%
Mar 31, 2025
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
